IRIDEX Corporation (NASDAQ:IRIX) – Analysts at Roth Capital issued their FY2016 EPS estimates for IRIDEX Corporation in a report released on Monday. Roth Capital analyst C. Lewis expects that the brokerage will post earnings of ($0.12) per share for the year. Roth Capital has a “Buy” rating and a $20.00 price objective on the stock. Roth Capital also issued estimates for IRIDEX Corporation’s Q4 2016 earnings at ($0.03) EPS.

TRADEMARK VIOLATION NOTICE: This piece of content was reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be read at http://www.watchlistnews.com/equities-analysts-set-expectations-for-iridex-corporations-fy2016-earnings-irix/1061195.html.

Shares of IRIDEX Corporation (NASDAQ:IRIX) opened at 13.94 on Thursday. The company has a 50-day moving average price of $14.54 and a 200-day moving average price of $14.67. The stock’s market cap is $141.46 million. IRIDEX Corporation has a 52 week low of $7.50 and a 52 week high of $16.64.

TRADEMARK VIOLATION NOTICE: This piece of content was reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be read at http://www.watchlistnews.com/equities-analysts-set-expectations-for-iridex-corporations-fy2016-earnings-irix/1061195.html.

About IRIDEX Corporation

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD).

5 Day Chart for NASDAQ:IRIX

Receive News & Ratings for IRIDEX Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.